D-0600-2020 Class II Terminated

Recalled by Coast Quality Pharmacy, LLC Dba Anazao Health — Tampa, FL

FDA drug recall D-0600-2020 was initiated by Coast Quality Pharmacy, LLC Dba Anazao Health on Sep 3, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi. The recall status is terminated (terminated Dec 1, 2020).

Recall details

Product Type
Drugs
Report Date
Dec 18, 2019
Initiation Date
Sep 3, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Morphine Sulfate and Bupivacaine HCL and Clonidine HCL in all strengths, all doses and all packaging AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634 (800) 995-4363

Reason for recall

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Distribution pattern

Nationwide in the U.S.

Code information

All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0600-2020
openFDA file date
Nov 17, 2026
Loaded by RegDataLab
Nov 18, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0600-2020. Report a data issue: hello@regdatalab.com.